COREMEDICO ApS: Financial statements 2024
CVR: 30070534
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
COREMEDICO ApS (CVR 30070534) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -24,655 and a net result of DKK -774,332 compared with DKK -319,899 the year before. Equity in the 2024 report amounted to DKK 1,060,606. The solvency ratio was 97.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -24,655
- Profit/Loss
- DKK -774,332
- Equity
- DKK 1,060,606
- Total Assets
- DKK 1,091,353
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -25 t. | -774 t. | 1.1 mio. | 1 |
| 2023 | - | 541 t. | -320 t. | 7 t. | 1 |
| 2022 | - | -10 t. | -63 t. | 326 t. | 0 |
| 2021 | - | -20 t. | -171 t. | 389 t. | 0 |
| 2020 | - | 31 t. | -15 t. | 560 t. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
COREMEDICO ApS has published its annual report for 2023. Gross profit came to DKK 540,649, and the net result was DKK -319,899.
About COREMEDICO ApS
COREMEDICO ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2006. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Kevin Hagemann Petersen. The company is owned by JOSARDI ApS. The company has 1 employee (2016). In 2025, the company reported a gross profit of DKK -71,962 and a net result of DKK -781,873 compared with DKK -774,332 the year before. Equity in the 2025 report amounted to DKK 1,278,734.